Satsuma Pharmaceuticals, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Satsuma Pharmaceuticals, Inc.
CIK #0001692830
EDGAR Form CIK 2011 - 2025
10-K [0001692830]
10-Q [0001692830]
3 [0001692830]
4 [0001692830]
8-K [0001692830]
D [0001692830]
SC 13D [0001692830]
SC 13G [0001692830]
Form 13D/13G Filer Form 13D/13G Subject Filed
BML Investment Partners LP Satsuma Pharmaceuticals Inc [2022-11-16]
Samlyn Capital LLC Satsuma Pharmaceuticals Inc [2022-02-14]
Shin Nippon Biomedical Laboratories Ltd Satsuma Pharmaceuticals Inc [2021-03-31]
Commodore Capital LP Satsuma Pharmaceuticals Inc [2021-03-15]
Growth Equity Opportunities 17 LLC Satsuma Pharmaceuticals Inc [2021-03-15]
Morgan Stanley Satsuma Pharmaceuticals Inc [2020-12-18]
TPG Group Holdings SBS Advisors Inc Satsuma Pharmaceuticals Inc [2020-02-13]
Osage University Partners III LP Satsuma Pharmaceuticals Inc [2019-11-27]
Caxton Corp Satsuma Pharmaceuticals Inc [2019-10-21]
Wellington Management Group LLP Satsuma Pharmaceuticals Inc [2019-10-10]
View All
Form 3/4/5 Subject 2011 - 2025
RA Capital Management LP
Kolchinsky Peter
Satsuma Pharmaceuticals, Inc.
RA Capital Healthcare Fund LP
Kollins John A
Soloway Thomas P
Sandoval Elisabeth
Riebe Michael T
Takanashi Ken
Shah Rajeev M.
View All
Terms | Privacy | Guide
tony@aum13f.com